Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Grebhardt · SciRah

Researcher profile · Semantic Scholar

S. Grebhardt

Share profile

S. Grebhardt — researcher profile on SciRah

h-index: 9
Works: 23
Citations: 306

Most-cited papers

Hypoxia and HIF‐1 increase S100A8 and S100A9 expression in prostate cancer
S. Grebhardt, C. Veltkamp, P. Ströbel, D. Mayer
2012International Journal of Cancer78 citations Open access
Semantic Scholar
Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy.
Dirk Theile, S. Grebhardt, W. Haefeli, J. Weiss
2009Biochemical Pharmacology68 citations Open access
Semantic Scholar
Impact of S100A8/A9 Expression on Prostate Cancer Progression In Vitro and In Vivo
S. Grebhardt, K. Müller-Decker, F. Bestvater, M. Hershfinkel +1 more
2014Journal of Cellular Physiology38 citations
Semantic Scholar
Prostaglandin E2 stimulates S100A8 expression by activating protein kinase A and CCAAT/enhancer-binding-protein-beta in prostate cancer cells.
Lin Miao, S. Grebhardt, Jian-Dang Shi, I. Peipe +2 more
2012International Journal of Biochemistry and Cell Biology24 citations
Semantic Scholar
Janus kinase 2--a novel negative regulator of estrogen receptor α function.
Nibedita Gupta, S. Grebhardt, D. Mayer
2012Cellular Signalling21 citations
Semantic Scholar
β-Catenin Is a Positive Regulator of Estrogen Receptor-α Function in Breast Cancer Cells
Nibedita Gupta, Fee Schmitt, S. Grebhardt, D. Mayer
2011Cancers19 citations Open access
Semantic Scholar
Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients
M. Metz, D. Semsek, G. Rogmans, U. Hutzschenreuter +13 more
2021Supportive Care in Cancer13 citations Open access
Semantic Scholar
Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in 2489 cancer patients: final results from the non-interventional study NADIR
T. Fietz, Andreas Lück, H. Schulz, J. Harde +7 more
2019Current Medical Research and Opinion11 citations
Semantic Scholar
Final Effectiveness and Safety Results of NABUCCO: Real‐World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab‐Paclitaxel
N. Marschner, C. Salat, U. Söling, R. Hansen +4 more
2018Clinical Breast Cancer11 citations Open access
Semantic Scholar
Prophylaxis of chemotherapy‐induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non‐Hodgkin lymphoma (NADIR study)
T. Wolff, H. Schulz, C. Losem, D. Reichert +7 more
2018European Journal of Haematology7 citations
Semantic Scholar
Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non‐interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials
T. Dechow, A. Aldaoud, T. Behlendorf, W. Knauf +8 more
2021European Journal of Haematology5 citations Open access
Semantic Scholar
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR
C. Gessner, T. Fietz, C. Losem, Andreas Lück +12 more
2022Current Medical Research and Opinion3 citations
Semantic Scholar
Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care
L. Sellmann, D. Marschner, U. M. Martens, J. Schröder +14 more
2026ESMO real world data and digital oncology2 citations
Semantic Scholar
IDHIRA: a prospective, observational study on ivosidenib in patients with IDH1 R132-mutated advanced cholangiocarcinoma
M. Michl, N. Hagemeyer, M. Looß, S. Grebhardt +2 more
2025Future Oncology2 citations Open access
Semantic Scholar
The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
U. Martens, Jan Schröder, F. Bengsch, L. Sellmann +12 more
2023BMC Cancer2 citations Open access
Semantic Scholar
1884P Patient, nurse and physician preferences: Final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or On-body injector (OBI) in cancer patients
M. Metz, D. Semsek, G. Rogmans, U. Hutzschenreuter +10 more
20202 citations Open access
Semantic Scholar
Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy – An Exploratory Analysis of the INFINITY Precision Oncology Registry
K. Potthoff, C. Vannier, U. Martens, M. Matter +17 more
2026OncoTargets and Therapy0 citations Open access
Semantic Scholar
Real-World Evidence for Oncology Patients With Rare NTRK Gene Fusions: Final Results From the German Multicenter Patient Cohort Study REALTRK
K. Potthoff, Sebastian Lange, T. Seufferlein, Kathrin Heinrich +9 more
2026JCO Precision Oncology0 citations Open access
Semantic Scholar
76P Second interim analysis of INFINITY: A registry on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
U. M. Martens, J. Schröder, L. Sellmann, M. Reiser +10 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
70P Genetic alterations and immune cell infiltration with potential impact on PD-(L)1 targeted treatment in various cancer entities: Biobank research project of the INFINITY registry
C. Vannier, P. Jermann, M. Matter, H. Läubli +4 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Routine clinical use of nab-paclitaxel for advanced / metastatic breast cancer in Germany: Final results of the prospective observational study NABUCCO.
J. Schroeder, K. Potthoff, C. Salat, U. Soeling +5 more
20170 citations
Semantic Scholar
293POverall survival and quality of life in patients with metastatic breast cancer treated with nab-paclitaxel: Final results of the non-interventional study NABUCCO
K. Potthoff, A. Nusch, U. Söling, R. Hansen +4 more
20170 citations Open access
Semantic Scholar
Abstract C49: Regulation of S100A8 and S100A9 expression by hypoxia and HIF-1 and their potential role as prognostic markers in prostate cancer
S. Grebhardt, C. Veltkamp, D. Mayer
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Potthoff×10
Invite
K. Potthoff — researcher profile on SciRah
J. Harde×8
Invite
J. Harde — researcher profile on SciRah
N. Marschner×7
Invite
N. Marschner — researcher profile on SciRah
D. Mayer×6
Invite
D. Mayer — researcher profile on SciRah

×6

Invite

C. Vannier — researcher profile on SciRah

Invite

T. Fietz — researcher profile on SciRah

S. Zacharias×4

Invite

S. Zacharias — researcher profile on SciRah

Invite

M. Zaiss — researcher profile on SciRah

Invite

K. Potthoff — researcher profile on SciRah

Invite

B. Kasenda — researcher profile on SciRah

Invite

H. Schulz — researcher profile on SciRah

Invite

C. Losem — researcher profile on SciRah